$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

$lgnd Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000088616315000110 Filed on November 09, 2015

Income Statement

Concept	2015 Q3	2014 Q4	2014 Q3
Revenue	$17.70M	$23.00M	$14.97M
YoY Change	18.22%	56.06%	15.13%
Cost Of Revenue	$1.250M	$4.000M	$1.496M
YoY Change	-16.44%	203.03%	-41.06%
Gross Profit	$16.45M	$19.00M	$13.48M
YoY Change	22.07%	41.58%	28.76%
Gross Profit Margin	92.94%	82.61%	90.01%
Selling, General & Admin	$4.970M	$5.520M	$6.740M
YoY Change	-26.26%	24.89%	41.6%
% of Gross Profit	30.21%	29.05%	50.01%
Research & Development	$1.945M	$3.280M	$3.021M
YoY Change	-35.62%	38.4%	25.14%
% of Gross Profit	11.82%	17.26%	22.42%
Depreciation & Amortization	$643.0K	$700.0K	$662.0K
YoY Change	-2.87%	0.0%	-0.9%
% of Gross Profit	3.91%	3.68%	4.91%
Operating Expenses	$1.945M	$8.800M	$3.021M
YoY Change	-35.62%	29.6%	25.14%
Operating Profit	$8.597M	$10.20M	$3.532M
YoY Change	143.4%	53.85%	15.05%
Interest Expense	$2.930M	-$2.910M	$1.516M
YoY Change	93.27%	809.38%	284.77%
% of Operating Profit	34.08%	-28.53%	42.92%
Other Income/Expense, Net	-$1.313M	$290.0K	-$2.631M
YoY Change	-50.1%	-107.07%	151.77%
Pretax Income	$7.284M	$7.010M	$901.0K
YoY Change	708.44%	248.76%	-55.51%
Income Tax	-$191.9M	$280.0K	$124.0K
% Of Pretax Income	-2634.28%	3.99%	13.76%
Net Earnings	$199.2M	$7.055M	$1.280M
YoY Change	15459.77%	277.47%	-34.86%
Net Earnings / Revenue	1125.16%	30.68%	8.55%
Basic Earnings Per Share	$10.01	$0.35	$0.06
Diluted Earnings Per Share	$9.28	$0.34	$0.06
COMMON SHARES
Basic Shares Outstanding	19.89M shares	19.88M shares	20.42M shares
Diluted Shares Outstanding	21.46M shares	20.79M shares	21.35M shares

Balance Sheet

Concept	2015 Q3	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$187.3M	$167.3M	$186.6M
YoY Change	0.38%	945.63%	5554.55%
Cash & Equivalents	$93.77M	$160.2M	$180.7M
Short-Term Investments	$93.50M	$7.100M	$5.900M
Other Short-Term Assets	$1.777M	$1.842M	$1.602M
YoY Change	10.92%	92.08%	5.95%
Inventory	$1.221M	$269.0K	$1.071M
Prepaid Expenses	$1.494M	$835.0K	$1.178M
Receivables	$5.500M	$12.60M	$5.800M
Other Receivables	$6.700M	$1.500M	$1.800M
Total Short-Term Assets	$210.3M	$185.2M	$198.5M
YoY Change	5.95%	644.17%	1093.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$355.0K	$486.0K	$551.0K
YoY Change	-35.57%	-43.94%	-33.93%
Goodwill	$12.24M	$12.24M	$12.24M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$48.94M	$50.72M	$51.32M
YoY Change	-4.63%	-4.47%	-4.42%
Long-Term Investments	$31.83M	$0.00
YoY Change
Other Assets	$248.0K	$207.0K	$230.0K
YoY Change	7.83%	-30.77%	-33.14%
Total Long-Term Assets	$286.0M	$72.87M	$73.76M
YoY Change	287.73%	-8.72%	-13.26%
TOTAL ASSETS
Total Short-Term Assets	$210.3M	$185.2M	$198.5M
Total Long-Term Assets	$286.0M	$72.87M	$73.76M
Total Assets	$496.3M	$258.0M	$272.3M
YoY Change	82.28%	146.42%	167.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.143M	$7.698M	$4.864M
YoY Change	-35.38%	94.84%	13.01%
Accrued Expenses	$4.156M	$4.866M	$4.311M
YoY Change	-3.6%	-8.83%	-6.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.300M	$2.400M	$2.900M
YoY Change	-55.17%	-79.83%	-80.92%
Total Short-Term Liabilities	$16.25M	$22.78M	$18.43M
YoY Change	-11.83%	-21.29%	-43.21%
LONG-TERM LIABILITIES
Long-Term Debt	$203.0M	$196.8M	$194.8M
YoY Change	4.21%	6248.39%	5164.86%
Other Long-Term Liabilities	$643.0K	$770.0K	$737.0K
YoY Change	-12.75%	10.79%	6.81%
Total Long-Term Liabilities	$643.0K	$770.0K	$737.0K
YoY Change	-12.75%	10.79%	6.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.25M	$22.78M	$18.43M
Total Long-Term Liabilities	$643.0K	$770.0K	$737.0K
Total Liabilities	$229.5M	$233.6M	$229.5M
YoY Change	0.01%	323.99%	303.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$435.8M	-$659.3M	-$666.4M
YoY Change	-34.6%	-1.79%	-1.02%
Common Stock	$20.00K	$20.00K	$20.00K
YoY Change	0.0%	-4.76%	-9.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$266.8M	$26.32M	$44.37M
YoY Change
Total Liabilities & Shareholders Equity	$496.3M	$258.0M	$272.3M
YoY Change	82.28%	146.42%	167.79%

Cashflow Statement

Concept	2015 Q3	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	$199.2M	$7.055M	$1.280M
YoY Change	15459.77%	277.47%	-34.86%
Depreciation, Depletion And Amortization	$643.0K	$700.0K	$662.0K
YoY Change	-2.87%	0.0%	-0.9%
Cash From Operating Activities	$10.50M	$10.30M	$3.700M
YoY Change	183.78%	-14.17%	-1333.33%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$1.000M	$0.00
YoY Change		900.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$26.30M	-$700.0K	$100.0K
YoY Change	-26400.0%	-22.22%	-200.0%
Cash From Investing Activities	-$26.40M	-$1.700M	$100.0K
YoY Change	-26500.0%	70.0%	-133.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.500M	-29.00M	162.3M
YoY Change	-99.08%	974.07%	-7828.57%
NET CHANGE
Cash From Operating Activities	10.50M	10.30M	3.700M
Cash From Investing Activities	-26.40M	-1.700M	100.0K
Cash From Financing Activities	1.500M	-29.00M	162.3M
Net Change In Cash	-14.40M	-20.40M	166.1M
YoY Change	-108.67%	-345.78%	-6251.85%
FREE CASH FLOW
Cash From Operating Activities	$10.50M	$10.30M	$3.700M
Capital Expenditures	$0.00	-$1.000M	$0.00
Free Cash Flow	$10.50M	$11.30M	$3.700M
YoY Change	183.78%	-6.61%	-1950.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000886163
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19925754	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	LIGAND PHARMACEUTICALS INC
CY2014Q4	lgnd	Capitalized Initial Public Offering Expenses CapitalizedInitialPublicOfferingExpenses	2268000	USD
CY2015Q3	lgnd	Capitalized Initial Public Offering Expenses CapitalizedInitialPublicOfferingExpenses	0	USD
CY2014Q4	lgnd	Co Promote Termination Payments Receivable Current CoPromoteTerminationPaymentsReceivableCurrent	322000	USD
CY2015Q3	lgnd	Co Promote Termination Payments Receivable Current CoPromoteTerminationPaymentsReceivableCurrent	0	USD
CY2014Q3	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	1157000	USD
	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	5441000	USD
CY2015Q3	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	1900000	USD
	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	3618000	USD
CY2014Q4	lgnd	Commercial License Rights CommercialLicenseRights	4568000	USD
CY2015Q3	lgnd	Commercial License Rights CommercialLicenseRights	8598000	USD
CY2014Q4	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	6796000	USD
CY2015Q3	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	7620000	USD
CY2014Q4	lgnd	Deposits Liabilities Noncurrent DepositsLiabilitiesNoncurrent	411000	USD
CY2015Q3	lgnd	Deposits Liabilities Noncurrent DepositsLiabilitiesNoncurrent	319000	USD
	lgnd	Effective Income Tax Rate Reconciliation Continuing Operations Percent EffectiveIncomeTaxRateReconciliationContinuingOperationsPercent	0.03
	lgnd	Effective Income Tax Rate Reconciliation Continuing Operations Percent EffectiveIncomeTaxRateReconciliationContinuingOperationsPercent	-5.96
CY2014Q3	lgnd	Exercise Priceof Convertible Bond Hedge ExercisePriceofConvertibleBondHedge	75.05
	lgnd	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Fair Value Adjustment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetFairValueAdjustment	68000	USD
	lgnd	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Co Promotion Termination FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentCoPromotionTermination	68000	USD
	lgnd	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Contingent Liabilities FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities	3064000	USD
CY2015Q3	lgnd	Income Tax Provision Per Diluted Share IncomeTaxProvisionPerDilutedShare	10.12
	lgnd	Income Tax Provision Per Diluted Share IncomeTaxProvisionPerDilutedShare	10.27
	lgnd	Lease Expiration Year Maximum LeaseExpirationYearMaximum	2019
	lgnd	Lease Expiration Year Minimum LeaseExpirationYearMinimum	2016
CY2014Q4	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	8353000	USD
CY2015Q3	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	7589000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3000	USD
CY2014Q4	lgnd	Long Term Portion Of Lease Exit Obligations LongTermPortionOfLeaseExitObligations	934000	USD
CY2015Q3	lgnd	Long Term Portion Of Lease Exit Obligations LongTermPortionOfLeaseExitObligations	0	USD
	lgnd	Maturity Period Of Highly Liquid Securities Maximum MaturityPeriodOfHighlyLiquidSecuritiesMaximum	P3M
	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-4880000	USD
	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-4976000	USD
	lgnd	Non Restricted Equity And Debt Securities With Maturity Period NonRestrictedEquityAndDebtSecuritiesWithMaturityPeriod	P3M
	lgnd	Noncash Upfront Fee NoncashUpfrontFee	1211000	USD
	lgnd	Noncash Upfront Fee NoncashUpfrontFee	0	USD
CY2014Q3	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	200000	USD
	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	400000	USD
CY2015Q3	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	300000	USD
	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	800000	USD
CY2015Q3	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Duein Rolling Year Five OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueinRollingYearFive	0	USD
CY2015Q3	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Duein Rolling Year Four OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueinRollingYearFour	209000	USD
CY2015Q3	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Duein Rolling Year Three OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueinRollingYearThree	286000	USD
CY2015Q3	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Duein Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueinRollingYearTwo	318000	USD
CY2015Q3	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Next Rolling Twelve Months OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsNextRollingTwelveMonths	2514000	USD
CY2015Q3	lgnd	Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Maximum OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMaximum	0.035
CY2015Q3	lgnd	Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Minimum OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMinimum	0.03
CY2014Q4	lgnd	Other Other Liabilities Noncurrent OtherOtherLiabilitiesNoncurrent	32000	USD
CY2015Q3	lgnd	Other Other Liabilities Noncurrent OtherOtherLiabilitiesNoncurrent	33000	USD
	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	1936000	USD
	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	4941000	USD
	lgnd	Paymentsfor Convertible Bond Hedges PaymentsforConvertibleBondHedges	48143000	USD
	lgnd	Paymentsfor Convertible Bond Hedges PaymentsforConvertibleBondHedges	0	USD
	lgnd	Purchasefor Commercial License Rights PurchaseforCommercialLicenseRights	0	USD
	lgnd	Purchasefor Commercial License Rights PurchaseforCommercialLicenseRights	4030000	USD
	lgnd	Sales Returns Restocking Fee Percent SalesReturnsRestockingFeePercent	0.2
CY2014Q3	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.086
CY2015Q3	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.085
	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.085
CY2014Q4	lgnd	Short Term Portion Of Lease Exit Obligations ShortTermPortionOfLeaseExitObligations	2356000	USD
CY2015Q3	lgnd	Short Term Portion Of Lease Exit Obligations ShortTermPortionOfLeaseExitObligations	1300000	USD
CY2014Q4	lgnd	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	809000	USD
CY2015Q3	lgnd	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	847000	USD
	lgnd	Variable Interest Entity Qualitativeor Quantitative Information Loss Percentage Recorded VariableInterestEntityQualitativeorQuantitativeInformationLossPercentageRecorded	1
CY2014Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	685000	USD
CY2015Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	283000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7698000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3143000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-73000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4866000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4156000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	459000	USD
CY2015Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	443000	USD
CY2014Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	705000	USD
CY2015Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	798000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2643000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2732000	USD
CY2014Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	11600000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4953000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5558000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	680660000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	697061000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	3702000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8795000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	2836000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	9511000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1223000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7646000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3300000	shares
CY2014Q4	us-gaap	Assets Assets	258029000	USD
CY2015Q3	us-gaap	Assets Assets	521700000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	186419000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	210324000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	8394000	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	94128000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4954000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5567000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	10000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	3440000	USD
CY2015Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	88571000	USD
CY2014Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-1620000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-4880000	USD
CY2015Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	2301000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-4976000	USD
CY2014Q3	us-gaap	Business Exit Costs1 BusinessExitCosts1	182000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	522000	USD
CY2015Q3	us-gaap	Business Exit Costs1 BusinessExitCosts1	345000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	786000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11639000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180663000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160203000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93770000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	169024000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-66433000	USD
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	247000	USD
CY2014Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	125.08
CY2014Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3264643	shares
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19918334	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	20000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	20000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-218000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8080000	USD
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	33333333	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	33333333	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19575150	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19918334	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19575150	shares
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	220874000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	249244000	USD
CY2014Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	195908000	USD
CY2015Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	202951000	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1496000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5133000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1250000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4923000	USD
CY2014Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2015Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	28190000	USD
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	327000	USD
CY2015Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	291000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1063000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	34000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2085000	USD
CY2015Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2083000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	0	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	7517000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	206423000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2792000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2014Q3	us-gaap	Depreciation Depreciation	100000	USD
	us-gaap	Depreciation Depreciation	200000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	100000	USD
	us-gaap	Depreciation Depreciation	200000	USD
CY2014Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	662000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1998000	USD
CY2015Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	643000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1940000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	11.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	12.61
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1708000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1485000	USD
CY2014Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2015Q3	us-gaap	Equity Method Investments EquityMethodInvestments	31826000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	390000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	5547000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	322000	USD
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	11.78
CY2014Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.09
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.03
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-29.83
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	6.81
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	5547000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	4074000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	390000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	11819000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10487000	USD
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2400000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2400000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2400000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2400000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2400000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	16000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6742000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17053000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4971000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18190000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	12238000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	12238000	USD
CY2014Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	901000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4291000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7284000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	29501000	USD
CY2014Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2015Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2169000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3040000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	131000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-217255000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-216976000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-321000	USD
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	16000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	19000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3478000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4993000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3590000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7142000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-116000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	216989000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-118000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	225000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	158000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1245000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	546000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	615000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	438000	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	0	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	-661000	USD
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	745591	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	402941	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	905593	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1010665	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	763856	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	922051	shares
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	50723000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48941000	USD
CY2014Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	62961000	USD
CY2015Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	61179000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	1516000	USD
	us-gaap	Interest Expense InterestExpense	1946000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	2930000	USD
	us-gaap	Interest Expense InterestExpense	8875000	USD
	us-gaap	Interest Paid InterestPaid	494000	USD
	us-gaap	Interest Paid InterestPaid	1822000	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	925000	USD
CY2015Q3	us-gaap	Interest Payable Current InterestPayableCurrent	956000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	269000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	1221000	USD
CY2014Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2015Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2014Q4	us-gaap	Liabilities Liabilities	233621000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	229519000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	258029000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	521700000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10320000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	28062000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22779000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16253000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-1910000	USD
CY2015Q3	us-gaap	Minority Interest MinorityInterest	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	159020000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6890000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-101385000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	1280000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4969000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	224539000	USD
	us-gaap	Net Income Loss NetIncomeLoss	248857000	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-503000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-809000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2380000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2631000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5698000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1313000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13188000	USD
CY2014Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	0	USD
CY2015Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	5547000	USD
CY2014Q4	us-gaap	Notes Payable NotesPayable	196242000	USD
CY2015Q3	us-gaap	Notes Payable NotesPayable	202951000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2014Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11441000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	31550000	USD
CY2015Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9104000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	34409000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3532000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	9989000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	8597000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	16313000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5219000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	3327000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Five OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive	0	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Four OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour	560000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Three OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree	746000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo	767000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Next Rolling Twelve Months OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths	3146000	USD
CY2014Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	800000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2600000	USD
CY2015Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	800000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2700000	USD
CY2015Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	9100000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1069000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	474000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1842000	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1777000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	207000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	248000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1224000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1870000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3059000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1978000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	274000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-1241000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	606000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1591000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	770000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	643000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	505000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1128000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1485000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1889000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-124000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-1000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	38523000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	489000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5711000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	9000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	111788000	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	835000	USD
CY2015Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1494000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	245000000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	11637000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	22967000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1496000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	5680000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4124000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7379000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	777000	USD
	us-gaap	Profit Loss ProfitLoss	4160000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	224539000	USD
	us-gaap	Profit Loss ProfitLoss	246477000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3129000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	355000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1241000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1988000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	12634000	USD
CY2015Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	5517000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9364000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3087000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	486000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2015Q3	us-gaap	Revenues Revenues	17701000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3021000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8842000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2538000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10510000	USD
CY2014Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1261000	USD
CY2015Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	600000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-659315000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-410458000	USD
CY2014Q3	us-gaap	Revenues Revenues	14973000	USD
	us-gaap	Revenues Revenues	41539000	USD
	us-gaap	Revenues Revenues	50722000	USD
CY2014Q3	us-gaap	Royalty Revenue RoyaltyRevenue	7482000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	20573000	USD
CY2015Q3	us-gaap	Royalty Revenue RoyaltyRevenue	9755000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	26648000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6334000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	15525000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6046000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	20456000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8795000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9511000	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.68
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.58
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.50
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.020
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.020
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.017
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	78685	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	287747	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1800697	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1712719	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.78
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.47
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	24.43
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	45.75
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	62.82
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y4M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y4M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M26D
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	7133000	USD
CY2015Q3	us-gaap	Short Term Investments ShortTermInvestments	93528000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	297040	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	26318000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	292181000	USD
CY2014Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	3388000	USD
CY2015Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	2747000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1870000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3082000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8300000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21345311	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21632521	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21459648	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21121972	shares
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20417187	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20584469	shares
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19886877	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19741081	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20417187	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20584469	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19886877	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19741081	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	22531	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	37387	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	63324	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	55899	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000886163-15-000110-index-headers.html	Edgar Link	pending
0000886163-15-000110-index.html	Edgar Link	pending
0000886163-15-000110.txt	Edgar Link	pending
0000886163-15-000110-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lgnd-20150930.xml	Edgar Link	completed
lgnd-20150930.xsd	Edgar Link	pending
lgnd-20150930_cal.xml	Edgar Link	unprocessable
lgnd-20150930_def.xml	Edgar Link	unprocessable
lgnd-20150930_lab.xml	Edgar Link	unprocessable
lgnd-20150930_pre.xml	Edgar Link	unprocessable
lgnd-9301510q.htm	Edgar Link	pending
lgnd_93015exhibit311.htm	Edgar Link	pending
lgnd_93015exhibit312.htm	Edgar Link	pending
lgnd_93015exhibit321.htm	Edgar Link	pending
ligand-amendmentno4tosubli.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

2015 Q3 Form 10-Q Financial Statement

#000088616315000110 Filed on November 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND LIGAND PHARMACEUTICALS INC Stock $lgnd

2015 Q3 Form 10-Q Financial Statement

#000088616315000110 Filed on November 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd